Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

Jardiance (empagliflozin), an SGLT-2 inhibitor, was recently approved by the FDA to help adults who have heart failure with reduced ejection fraction (HFrEF). Results from EMPEROR-Preserved also show Jardiance benefits those with heart failure with preserved ejection fraction (HFpEF). Continue Reading »

At the ADCES 2021 conference three diabetes care and education specialists gave their recommendations for how to craft an individual exercise routine and how to avoid common pitfalls. Continue Reading »

Curious to know what apps are available to you to help you manage a variety of health conditions? At the ADCES 2021 conference, experts discussed the best options out there from diabetes prevention to weight management to exercise and more. Continue Reading »

A survey jointly conducted by diabetes research company dQ&A and The diaTribe Foundation assessed how well endocrinologists understood Time in Range and which diabetes metrics they consider most important for setting treatment goals. Continue Reading »

The Association of Diabetes Care and Education Specialists 2021 conference covered the impacts of diabetes stigma, smart MDI therapies, insulin delivery by means other than an insulin pump, the latest in diabetes tech, and more! Continue Reading »

When it comes to SGLT-2s and GLP-1s, there are several medicines available. Read below for more information on these therapies which have particular benefits for those with heart and/or kidney disease. Continue Reading »

Social determinants of health describe the interaction between social, economic, and environmental factors and how they can influence a person’s health. Read below for insights from the 81st ADA Scientific Sessions on SDOH and how they impact people with diabetes. Continue Reading »

For decades, researchers have sought to develop a noninvasive method to measure blood glucose levels, which – if effective – could revolutionize diabetes care. One company in Israel now has such a device in development. Learn about the origins of this technology, its early success, and what this could mean for people with diabetes. Continue Reading »

Pages